ADMA Biologics Inc (NASDAQ:ADMA) issued its quarterly earnings data on Friday. The company reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.37) by $0.06. In related news, Director Jerrold B. Grossman purchased 45,769 shares of the stock in a transaction dated Tuesday, May 3rd. The shares were acquired at an average cost […]
